ストックスクリーナーアプリを入手
7.35
1.34%
-0.14
Neonc Technologies Holdings Inc (NTHI) 最新ニュース
NeOnc Technologies appoints new chief clinical officer - Investing.com India
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs - The Manila Times
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance ... - Bluefield Daily Telegraph
Neonc technologies CFO Garnett Keithly sells $164,425 in stock - Investing.com
"New Frontiers" Presents Featuring Athena Clinic, MonDak Portables, LLC, NeOnc Technologies Holdings, Inc. & Hollobus Technologies. The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios.NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Neonc technologies CFO Garnett Keithly acquires $976 in shares By Investing.com - Investing.com South Africa
Neonc technologies CFO Garnett Keithly acquires $976 in shares - Investing.com Australia
Major Stock Acquisition by NeOnc Technologies’ President! - TipRanks
NeOnc Technologies Appoints New President Amid Strategic Moves - MSN
Clinical Trial of NEO100 Recruiting Patients With Malignant Gliomas - Curetoday
NeOnc Technologies announces global patent portfolio totals 176 - TipRanks
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets - The Manila Times
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical - Bluefield Daily Telegraph
NeOnc Sees Share Price Fall Since Going Public - Los Angeles Business Journal
NeOnc Technologies expects full enrollment in Phase 2a trial of NEO100-01 - TipRanks
NeOnc Technologies Expects Full Enrollment in Phase 2a Trialfor NEO100-01 by September - marketscreener.com
Neonc Technologies Holdings Expects Full Enrollment In Promising Phase 2A Trial Of Neo100-01 For Malignant Gliomas In September - MarketScreener
NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September - The Manila Times
Planet TV Studios Airing “New Frontiers” Episode on NeOnc Technologies Holdings, Inc. – Saturday, April 26th, - EIN News
New CEOs at Alterome, Valo and Imbria - BioCentury
NeOnc Technologies Appoints Executive Chairman Amir Heshmatpour as President - MarketScreener
NeOnc Technologies Holdings, Inc. Executive Chairman, Amir - GlobeNewswire
Germany's economy is expected to stagnate at best this year - The Globe and Mail
2 Reasons Nu Holdings Stock Is a Buy Before May 13 - The Globe and Mail
Rigetti Computing Stock (RGTI) Surges 21% as Market Optimism Returns - The Globe and Mail
NeOnc Technologies Phase 1 Trial Enrollment for NEO212 Brain Cancer Drug Nears Full Enrollment - MarketScreener
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy - GlobeNewswire
Dow Jones Index Daily Report: DIA Rebounds Today After Tariff Tantrum - The Globe and Mail
Nvidia Stock (NVDA) Smashes Back as AI Demand Counters Tariff Panic - The Globe and Mail
NeOnc Technologies Partners with CBCC for Clinical Expansion - TipRanks
Neonc Technologies appoints new accounting firm By Investing.com - Investing.com Canada
Neonc Technologies appoints new accounting firm - Investing.com India
NeOnc Technologies receives RPDD for NEO100 - TipRanks
NeOnc Technologies Holdings: New IPO gets a Rare Pediatric Disease Designation and a 37.92% Jump in the Market - RagingBull
NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation - MarketScreener
NeOnc Falls Despite FDA Nod - Baystreet.ca
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric - GlobeNewswire
Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas - Yahoo Finance
NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments - The Manila Times
NeOnc Technologies Expands Global Clinical Trial Network - GlobeNewswire
NeOnc Technologies Holdings, Inc. Rings the Opening Bell - Nasdaq
NTHI IPO NewsBiotech NeOnc Technologies' share registration declared effective ahead of Nasdaq direct listing - renaissancecapital.com
NeOnc Technologies Holdings Announces Effectiveness of - GlobeNewswire
NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market - Yahoo Finance
NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors - Yahoo Finance
NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors - GlobeNewswire
NeOnc Technologies Holdings, Inc. Appoints Bader Almonawer to Board of Directors - GlobeNewswire
NEONC Technologies Holdings, Inc. Appoints Renowned Neurosurgeon Dr. Steven L. Giannotta to its Board of Directors - The Manila Times
NeOnc Technologies Holdings, Inc. Appoints Dr. Steven L. Giannotta to Board of Directors - Nasdaq
Nasdaq’s opening bell will ring for USC research startup NeOnc - USC Today
1.30%
3.35%
大文字化:
|
ボリューム (24 時間):